Open innovation networks in Indian pharmaceutical sector

Bhawani Bhatnagar, Viktor Dörfler, Jillian MacBryde

Research output: Contribution to conferencePaperpeer-review

208 Downloads (Pure)


The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?

The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.
Original languageEnglish
Publication statusPublished - 9 Sep 2015
EventBAM 2015: The 29th Annual Conference of the British Academy of Management Conference - University of Portsmouth, Portsmouth, United Kingdom
Duration: 8 Sep 201510 Sep 2015


ConferenceBAM 2015: The 29th Annual Conference of the British Academy of Management Conference
Abbreviated titleBAM 2015
Country/TerritoryUnited Kingdom
Internet address


  • patent protection
  • open innovation
  • Indian pharmaceutical sector
  • patent regime


Dive into the research topics of 'Open innovation networks in Indian pharmaceutical sector'. Together they form a unique fingerprint.

Cite this